# Safety and Efficacy of Preoperative Antithrombin Supplementation in Patients Undergoing High-Risk Cardiopulmonary Bypass

> **NCT02037555** · PHASE2 · COMPLETED · sponsor: **Grifols Therapeutics LLC** · enrollment: 425 (actual)

## Conditions studied

- Cardiac Surgery
- Cardiopulmonary Bypass

## Interventions

- **BIOLOGICAL:** AT-III (Human)
- **OTHER:** Placebo

## Key facts

- **NCT ID:** NCT02037555
- **Lead sponsor:** Grifols Therapeutics LLC
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-06-26
- **Primary completion:** 2018-01-25
- **Final completion:** 2018-01-25
- **Target enrollment:** 425 (ACTUAL)
- **Last updated:** 2019-03-15

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02037555

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02037555, "Safety and Efficacy of Preoperative Antithrombin Supplementation in Patients Undergoing High-Risk Cardiopulmonary Bypass". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT02037555. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*